Femtosecond Laser-assisted Anterior Lamellar Keratoplasty
Study Details
Study Description
Brief Summary
The purpose of the study is evaluating safety and clinical efficiency of full femtosecond laser-assisted anterior lamellar keratoplasty (FS-ALK) for curing patients with keratoconus and corneal opacities
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Keratoplasty is the most widely spread tissue transplantation procedure. Although penetrating keratoplasty (PKP) is still commonly used for curing corneal dystrophy and opacities of different genesis, lamellar techniques provide significant advantages in terms of safety and predictability.
Al in all 13 FS-ALK procedures were performed for 11 eyes with advanced keratoconus and 2 eyes with superficial corneal scattering Before and after surgery uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), postoperative astigmatism, endothelial cell loss, central cornea thickness, residual recipient's tissue thickness, corneal hysteresis (CH) and corneal resistance factor (CFR) were evaluated . At 1-year follow-up Confoscan investigation of donor-recipient interface was performed.
All FS-ALK procedures were performed with Intralase FS 60kHz femtosecond laser in a following way. At first a 80% thickness corneal graft was prepared. Then maximum thickness recipients corneal dissection was performed according to OCT (optical coherence tomography) data and superficial tissue was removed. Transplant was fixed in a resulted bed by continuous suture.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: FS-ALK Femtosecond laser-assisted maximum thickness anterior lamellar keratoplasty (FS-ALK) was performed for 11 eyes of 11 patients with advanced keratoconus and 2 eyes of 2 patients with superficial corneal scattering. |
Procedure: FS-ALK (Femtolaser-assisted anterior lamellar keratoplasty)
The procedure was a non-penetrating transplantation of 80% thickness corneal graft
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Mean endothelial cell loss [12 months after surgery]
- Mean postoperative astigmatism [12 months after surgery]
- UCVA (uncorrected visual acuity) [12 months after surgery]
- BSCVA (best spectacle-corrected visual acuity) [12 months after surgery]
Secondary Outcome Measures
- Corneal hysteresis [12 months after surgery]
Evaluation of biomechanical qualities of the cornea
- Corneal resistance factor [12 months after surgery]
Evaluation of biomechanical qualities of the cornea
- Central corneal thickness [12 months after surgery]
measured by OCT (optical coherence tomography - Optovue)
- Residual recipient's tissue thickness [12 months after surgery]
measured by OCT (optical coherence tomography - Optovue)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Advanced keratoconus or stromal corneal scattering
-
Normal endothelial cell density
Exclusion Criteria:
-
Acute keratoconus in the anamnesis
-
Low endothelial cell density
-
Age under 18 years
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- The S.N. Fyodorov Eye Microsurgery State Institution
Investigators
- Study Director: Boris Malyugin, MD,PhD,prof., The S.N. Fedorof Federal State Institution
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FS-1